Drug Profile
Insulin rectal - Oramed Pharmaceuticals
Alternative Names: Insulin suppository; ORMD 0802Latest Information Update: 21 Jan 2022
Price :
$50
*
At a glance
- Originator Oramed Pharmaceuticals
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 1 diabetes mellitus